Healthcare knows no borders, and cooperation builds the future. On July 17, an international medical delegation of over 20 leading overseas experts, including Indonesian surgeon Dr AVRIANA PETY WARDANI, representatives from multiple Indonesian medical institutions, Lebanese expert Dr TAREK GHANNAM, and American expert MR AGUNG HENDRYANTO, visited Guangzhou Royal Lee Cancer Hospital under the leadership of Ms. Zhong Jiayan, President of the Indonesian Overseas Chinese Association. The delegation conducted an indepth and comprehensive investigation into our hospital’s international medical service system, global operational models, and cuttingedge oncology technologies. This multinational visit not only served as a professional assessment by the global healthcare community of our years of achievements in crossborder oncology care, but also reaffirmed that Royal Lee’s international specialty strength continues to gain widespread recognition from peers worldwide.

On behalf of the entire hospital, our CEO YEO KIM SECK, Chief Advisor Jiang Wenqi, and Vice President and Head of International Medical Services Ma Lanying extended a warm welcome to the visiting international expert delegation and accompanied them throughout the onsite inspection and discussions.

The delegation visited our International Medical Center, Precision Oncology Center, and stateoftheart diagnostic and therapeutic equipment zones, immersing themselves in our standardized fullprocess clinical protocols, refined humanistic service management, worldclass hardware infrastructure, and efficient, mature international clinical operation loop. From multilingual onestop patient reception and precision minimally invasive oncology techniques to the full chain of crossborder medical support services, the delegation experienced our unique approach that balances professional excellence with humanistic warmth. They were deeply impressed by our profound technical expertise and forwardlooking strategic layout in the oncology field.

Dr AVRIANA PETY WARDANI

Dr TAREK GHANNAM

Mr AGUNG HENDRYANTO

As a JCIaccredited tertiary cancer hospital in the GuangdongHong KongMacao Greater Bay Area, Royal Lee leverages the nationallevel bilateral cooperation platform of the China-Singapore Guangzhou Knowledge City to build a crossborder oncology service network that reaches across the globe. Clinically, the hospital has deep expertise in Y90 microsphere therapy, minimally invasive ablation, gene therapy, and innovative anticancer drug applications, developing comprehensive personalized precision treatment plans for complex tumors. On the service front, we have established a multilingual professional team and offer a onestop crossborder medical service system covering visa coordination, dedicated transfers, international MDT teleconsultations, and direct billing with global commercial insurance. To date, we have delivered highquality, compassionate international care to cancer patients from over 30 countries and regions.

CEO YEO KIM SECK

Zhong Jiayan, President of the Indonesian Overseas Chinese Association

After the site visits, both sides held a dedicated exchange symposium. The international delegation spoke highly of our strong oncology diagnostic and therapeutic capabilities and our comprehensive, mature international service infrastructure, unanimously affirming that Royal Lee’s overall standards, clinical quality, and crossborder service systems are on par with leading international medical institutions.

Chief Advisor Jiang Wenqi

Vice President  Ma Lanying

During the symposium, experts from China and abroad exchanged views on key topics including oncology research, physician exchange and training programs, crossborder multidisciplinary team consultations, and collaborative implementation of advanced anticancer technologies. They reached a multilevel, longterm consensus on deep cooperation, planning to jointly establish channels for transnational clinical collaboration, thereby connecting cancer patients in Indonesia, Lebanon, the United States, and other countries with premier global oncology resources.

At the conclusion of the exchange, in the presence of CEO Mr. YEO KIM SECK, Ms. Zhong Jiayan, President of the Indonesian Overseas Chinese Association, and experts from various countries, Vice President Ma Lanying, on behalf of Guangzhou Royal Lee Cancer Hospital, formally signed international medical cooperation agreements with Lebanese expert Dr TAREK GHANNAM and American expert Mr AGUNG HENDRYANTO respectively. This marks another expansion of our global medical cooperation network and signals that transnational oncology collaboration has entered a concrete implementation phase.

With a deep commitment to international healthcare and building bridges for global collaboration, this joint visit and strategic cooperation signing represent a significant milestone in Royal Lee’s international development journey. Moving forward, our hospital will continue to leverage its benchmark position in crossborder oncology care within the Greater Bay Area, connect global medical resources with an open mind, and contribute our professional expertise to the coordinated advancement of global cancer care—ensuring that advanced oncology technologies benefit patients around the world.